Howe & Rusling’s Tenet Healthcare THC Stock Holding History

Howe & Rusling’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-500	Closed	-$9K	–	1019
2017 Q1	$9K	Buy	+500	New	+$9.27K	﹤0.01%	539

Other funds holding THC

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Howe & Rusling's THC Position: Q2 2017 in Review

Howe & Rusling sold out of Tenet Healthcare (THC) in Q2 2017, closing a stake of 500 shares — an estimated $9K sold.

Howe & Rusling first reported a position in THC in Q1 2017 and held it in 1 quarter. The position peaked at $9K in Q1 2017. 246 funds tracked by Wall St. Rank hold THC as of Q2 2017.

Howe & Rusling reported no remaining Tenet Healthcare position as of Q2 2017 after selling out during the quarter.
Howe & Rusling sold 500 Tenet Healthcare shares in Q2 2017, an estimated $9K.
Howe & Rusling first reported a position in Tenet Healthcare in Q1 2017 and held it in 1 quarter.
Howe & Rusling's Tenet Healthcare position peaked at $9K in Q1 2017.
246 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2017.

Based on Howe & Rusling's 13F filing for Q2 2017, filed 13 Jul 2017.